141 related articles for article (PubMed ID: 37915091)
1. Epidemiology and survival outcomes of HIV-associated cervical cancer in Nigeria.
Musa J; Kocherginsky M; Magaji FA; Maryam AJ; Asufi J; Nenrot D; Burdett K; Katam N; Christian EN; Palanisamy N; Odukoya O; Silas OA; Abdulkareem F; Akpa P; Badmos K; Imade GE; Akanmu AS; Gursel DB; Zheng Y; Joyce BT; Achenbach CJ; Sagay AS; Anorlu R; Wei JJ; Ogunsola F; Murphy RL; Hou L; Simon MA
Infect Agent Cancer; 2023 Nov; 18(1):68. PubMed ID: 37915091
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and Survival outcomes of HIV-associated cervical cancer in Nigeria.
Musa J; Kocherginsky M; Magaji FA; Maryam AJ; Asufi J; Nenrot D; Burdett K; Katam N; Christian EN; Palanisamy N; Odukoya O; Silas OA; Abdulkareem F; Akpa P; Badmos K; Imade GE; Akanmu AS; Gursel DB; Zheng Y; Joyce BT; Achenbach CJ; Sagay AS; Anorlu R; Wei JJ; Ogunsola F; Murphy RL; Hou L; Simon MA
medRxiv; 2023 Aug; ():. PubMed ID: 37609183
[TBL] [Abstract][Full Text] [Related]
3. Cervical cancer survival in a resource-limited setting-North Central Nigeria.
Musa J; Nankat J; Achenbach CJ; Shambe IH; Taiwo BO; Mandong B; Daru PH; Murphy RL; Sagay AS
Infect Agent Cancer; 2016; 11():15. PubMed ID: 27014366
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Impact of HIV infection on access to cancer care and survival among women with invasive cervical cancer in Côte d'Ivoire: A prospective cohort study.
Boni SP; Horo A; Didi-Kouko-Coulibaly J; Tanon A; Tchounga BK; Coffie PA; Comoe JC; Moh RD; Dabis F; Adoubi I; Jaquet A;
Int J Gynaecol Obstet; 2023 Nov; 163(2):392-401. PubMed ID: 37350012
[TBL] [Abstract][Full Text] [Related]
6. Accelerated Epigenetic Age Among Women with Invasive Cervical Cancer and HIV-Infection in Nigeria.
Musa J; Kim K; Zheng Y; Qu Y; Joyce BT; Wang J; Nannini DR; Gursel DB; Silas O; Abdulkareem FB; Imade G; Akanmu AS; Wei JJ; Kocherginsky M; Kim KA; Wehbe F; Achenbach CJ; Anorlu R; Simon MA; Sagay A; Ogunsola FT; Murphy RL; Hou L
Front Public Health; 2022; 10():834800. PubMed ID: 35570901
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and predictors of precancerous cervical lesions among HIV-positive women in Jos, north-central Nigeria.
Daniel GO; Musa J; Akindigh TM; Shinku F; Shuaibu SI; Kwaghe B; Afolaranmi T; Okpala C; Agbaji O; Sagay A
Int J Gynaecol Obstet; 2020 Nov; 151(2):253-259. PubMed ID: 32683675
[TBL] [Abstract][Full Text] [Related]
8. Invasive cervical cancer in HIV-infected women: risk and survival relative to those of the general population in France. Results from the French Hospital Database on HIV (FHDH)-Agence Nationale de Recherches sur le SIDA et les Hépatites Virales (ANRS) CO4 cohort study.
Grabar S; Hleyhel M; Belot A; Bouvier AM; Tattevin P; Pacanowski J; Genet P; Pradier C; Salmon D; Simon A; Pourcher V; Spano JP; Poizot-Martin I; Costagliola D
HIV Med; 2019 Mar; 20(3):222-229. PubMed ID: 30693646
[TBL] [Abstract][Full Text] [Related]
9. HIV status, age at cervical Cancer screening and cervical cytology outcomes in an opportunistic screening setting in Nigeria: a 10-year Cross sectional data analysis.
Musa J; Achenbach CJ; Evans CT; Jordan N; Daru PH; Silas O; Sagay AS; Anorlu R; Mehta SD; Wehbe F; Simon MA; Adewole IF; Hou L; Murphy RL
Infect Agent Cancer; 2019; 14():43. PubMed ID: 31798680
[TBL] [Abstract][Full Text] [Related]
10. INVASIVE CERVICAL CANCER IN IBADAN: SOCIO-SEXUAL CHARACTERISTICS, CLINICAL STAGE AT PRESENTATION, HISTOPATHOLOGY DISTRIBUTIONS AND HIV STATUS.
Awolude OA; Oyerinde SO
Afr J Infect Dis; 2019; 13(1):32-38. PubMed ID: 30596194
[TBL] [Abstract][Full Text] [Related]
11. High-risk human papilloma virus and cervical abnormalities in HIV-infected women with normal cervical cytology.
Musa J; Achenbach C; Taiwo B; Berzins B; Silas O; Daru PH; Agbaji O; Imade G; Sagay AS; Idoko JA; Kanki PJ; Murphy RL
Infect Agent Cancer; 2014; 9(1):36. PubMed ID: 25395987
[TBL] [Abstract][Full Text] [Related]
12. Frequency of high-grade squamous cervical lesions among women over age 65 years living with HIV.
Massad LS; Xie X; Minkoff HL; Michel KG; D'Souza G; Wang CC; Konkle-Parker D; Ofotokun I; Fischl MA; Rahangdale L; Strickler HD
Am J Obstet Gynecol; 2021 Oct; 225(4):411.e1-411.e7. PubMed ID: 33957115
[TBL] [Abstract][Full Text] [Related]
13. Cervical cancer risk and impact of Pap-based screening in HIV-positive women on antiretroviral therapy in Johannesburg, South Africa.
Rohner E; Sengayi M; Goeieman B; Michelow P; Firnhaber C; Maskew M; Bohlius J
Int J Cancer; 2017 Aug; 141(3):488-496. PubMed ID: 28440019
[TBL] [Abstract][Full Text] [Related]
14. Cervical Cancer Histology, Staging and Survival before and after Implementation of Organised Cervical Screening Programme in Poland.
Nowakowski A; Cybulski M; Buda I; Janosz I; Olszak-Wąsik K; Bodzek P; Śliwczyński A; Teter Z; Olejek A; Baranowski W
PLoS One; 2016; 11(5):e0155849. PubMed ID: 27196050
[TBL] [Abstract][Full Text] [Related]
15. Survival of cervical cancer patients at Moi teaching and Referral Hospital, Eldoret in western Kenya.
Mwaliko E; Itsura P; Keter A; De Bacquer D; Buziba N; Bastiaens H; Jackie A; Obala A; Naanyu V; Gichangi P; Temmerman M
BMC Cancer; 2023 Nov; 23(1):1104. PubMed ID: 37957644
[TBL] [Abstract][Full Text] [Related]
16. Outcome of HIV-associated lymphoma in a resource-limited setting of Jos, Nigeria.
Silas OA; Achenbach CJ; Hou L; Murphy RL; Egesie JO; Sagay SA; Agbaji OO; Agaba PE; Musa J; Manasseh AN; Jatau ED; Dauda AM; Akanbi MO; Mandong BM
Infect Agent Cancer; 2017; 12():34. PubMed ID: 28592989
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa.
Denny L; Adewole I; Anorlu R; Dreyer G; Moodley M; Smith T; Snyman L; Wiredu E; Molijn A; Quint W; Ramakrishnan G; Schmidt J
Int J Cancer; 2014 Mar; 134(6):1389-98. PubMed ID: 23929250
[TBL] [Abstract][Full Text] [Related]
18. High-risk human papillomavirus status and prognosis in invasive cervical cancer: A nationwide cohort study.
Lei J; Ploner A; Lagheden C; Eklund C; Nordqvist Kleppe S; Andrae B; Elfström KM; Dillner J; Sparén P; Sundström K
PLoS Med; 2018 Oct; 15(10):e1002666. PubMed ID: 30273338
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up on HIV infected and non-infected women with cervical cancer from Tanzania: staging, access to cancer-directed therapies and associated survival in a real-life remote setting.
Glasmeyer L; Mcharo RD; Torres L; Lennemann T; Danstan E; Mwinuka N; Judick M; Mueller W; Mbuya W; Hölscher M; Lellé R; Geldmacher C; Kroidl A; France JR
BMC Cancer; 2022 Aug; 22(1):892. PubMed ID: 35971100
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
